Ragheb AbuRmaileh

Title: Innovations by Ragheb AbuRmaileh in Fentanyl Formulations

Introduction

Ragheb AbuRmaileh is an accomplished inventor based in Bedford, OH (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable liquid formulations for parenteral administration of fentanyl.

Latest Patents

Ragheb holds two patents, both focused on ready-to-administer fentanyl formulations. These stable liquid formulations include fentanyl or a pharmaceutically acceptable salt thereof. The formulations consist of a diluent and buffer, which may contain sodium, in an aqueous solution with a pH ranging from about 3 to about 4.5. The parenteral liquid formulations are designed to be stable and are supplied as ready-to-administer products in infusion containers or bags. These formulations undergo terminal sterilization in the infusion container, ensuring their suitability for administration to patients requiring therapy with fentanyl or its salts.

Career Highlights

Ragheb AbuRmaileh is associated with Hikma Pharmaceuticals International Limited, where he continues to innovate in the pharmaceutical sector. His work focuses on enhancing the safety and efficacy of fentanyl administration, which is crucial for patient care.

Collaborations

Ragheb collaborates with notable colleagues, including Andrew Conrad and Ragheb Al-Shakhshir, contributing to a dynamic and innovative work environment.

Conclusion

Ragheb AbuRmaileh's contributions to fentanyl formulations exemplify the importance of innovation in the pharmaceutical industry. His patents reflect a commitment to improving patient care through advanced medical solutions.